Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial

Author:

Buse John B.1ORCID,Carlson Anders L.2,Komatsu Mitsuhisa3,Mosenzon Ofri4,Rose Ludger5,Liang Bo6,Buchholtz Kristine6,Horio Hiroshi7,Kadowaki Takashi8

Affiliation:

1. Division of Endocrinology, Department of Medicine, University of North Carolina School of Medicine; North Carolina

2. International Diabetes Center; Minneapolis Minnesota

3. Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine; Shinshu University School of Medicine; Nagano Japan

4. Diabetes Unit, Division of Internal Medicine; Hadassah Hebrew University Hospital; Jerusalem Israel

5. Institute of Diabetes Research; Münster Germany

6. Novo Nordisk A/S; Søborg Denmark

7. Novo Nordisk Pharma Ltd; Tokyo Japan

8. Department of Diabetes and Metabolic Diseases, Graduate School of Medicine; The University of Tokyo; Tokyo Japan

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3